Hims & Hers Health, Inc.
Hims & Hers Health, Inc. is classed by the SEC under Services-Offices & Clinics of Doctors of Medicine (industry code 8011), based in San Francisco, CA. In its latest annual figures on file, for the fiscal year ended 2025-12-31, it reported revenue of $2.3 billion and a profit of $128 million (its filed statements).
vs its business-model standard
Three tenses, nine metrics. Unseen metrics stay unseen; the grade never fakes a number. Proxy era: provisional values, marked. Weighed as a usage business: prior from its industry code (SEC 8011, Services-Offices & Clinics of Doctors of Medicine); the filing read can change it. All three tenses have at least two readings, so the archetype blend applies as printed.
The grade, in three tenses
Headline 6.4 out of ten, 9 of 9 metrics filed: past 5.8 out of ten, present 6.8 out of ten, future 6.5 out of ten. The past asks what it actually did, the present what it is doing right now, the future what it is set up to do next.
The nine metrics
- Surviving crises (past): 3.3 out of ten. 2 warning events since 2019; the latest 2021-05-04. 33rd percentile among 9 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Track record (past): 7.3 out of ten. +74.7% a year over 7 filed years; profitable in 2 of 7. 73rd percentile among 8 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Shareholder treatment (past): 6.5 out of ten. Share count grew 8.1% a year. 28% of cash flow returned. Insiders: 58 sales, 1 purchases. 65th percentile among 6 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Financial health (present): 5.7 out of ten. ROE 24%: 24¢ of profit per shareholder dollar. Leverage 75%: owes 75¢ per asset dollar. 57th percentile among 9 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Industry position (present): 8.1 out of ten. top 19% of 9 in its family; net margin 5.5%. 81st percentile among 9 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Leadership (present): 5.7 out of ten. top 43% of 5 in its family for leadership; chief executive since 2021. 57th percentile among 5 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-09).
- Room to expand (future): 5.7 out of ten. top 43% of 9 in its family for room to expand. 57th percentile among 9 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Growth drivers (future): 7.7 out of ten. top 23% of 8 in its family for growth drivers. 77th percentile among 8 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
- Expectations vs reality (future): 5.3 out of ten. top 47% of 6 in its family for expectations against reality. 53rd percentile among 6 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
The filing record
Newest annual report: Form 10-K filed 2026-02-23 for the period ended 2025-12-31 (on EDGAR). Newest quarterly report: Form 10-Q filed 2026-08-10 for the period ended 2026-06-30 (on EDGAR). Newest results release: Form 8-K filed 2026-08-10 (on EDGAR). Newest filing: Form 8-K, 2026-10-07. Filings on record since 2019. Read from EDGAR 2026-10-12.
Where the revenue comes from
By geography: United States 94%, Outside the United States 6%. As tagged in its annual report (Form 10-K, filed 2026-02-23).
Who runs it
Dudum, Andrew (Chief Executive Officer); Okupe, Oluyemi (Chief Financial Officer); Chi, Michael (Chief Operating Officer); Boughton, Soleil (Chief Legal Officer); Autor, Deborah M. (Chief Policy Officer); Carroll, Patrick Harrison (Chief Medical Officer); Elshenawy, Mohamed (CTO); Becklund, Irene (PAO); Payne, Christopher D (director); Schultz, Kare (director); and 6 more. 16 officers and directors have filed their own trades in the last fifteen months, names and titles as filed with the SEC, through 2026-10-02.
This file: Overview · Past · Present · Future · Filings · every company on file
Every stock is a company. We grade the company behind the stock. CrossAssetData is a company research product: no investment advice, no price targets, no price predictions; every claim carries its source, and unseen means unseen. The full file draws when the page's script runs: the essentials, the balance sheet, the estimators, the trend, and every filing of the last ten years.